Terms: = Liver cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Staging
6 results:
1. Nano-Gold PCR in Detection of
Zhao J; Li L; Guo L; Wang R; Zhao Y; Li W; Liu Y; Ma Y; Jia J
J Biomed Nanotechnol; 2021 Jul; 17(7):1284-1292. PubMed ID: 34446132
[TBL] [Abstract] [Full Text] [Related]
2. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
Joseph NM; Tsokos CG; Umetsu SE; Shain AH; Kelley RK; Onodera C; Bowman S; Talevich E; Ferrell LD; Kakar S; Krings G
J Pathol; 2019 Jun; 248(2):164-178. PubMed ID: 30690729
[TBL] [Abstract] [Full Text] [Related]
3. Goals and targets for personalized therapy for HCC.
Couri T; Pillai A
Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
[TBL] [Abstract] [Full Text] [Related]
4. Personal exposure to mixtures of volatile organic compounds: modeling and further analysis of the RIOPA data.
Batterman S; Su FC; Li S; Mukherjee B; Jia C;
Res Rep Health Eff Inst; 2014 Jun; (181):3-63. PubMed ID: 25145040
[TBL] [Abstract] [Full Text] [Related]
5. Biological prognostic factors in adult soft tissue sarcomas.
Ottaiano A; De Chiara A; Fazioli F; Talamanca AA; Mori S; Botti G; Milano A; Apice G
Anticancer Res; 2005; 25(6C):4519-26. PubMed ID: 16334136
[TBL] [Abstract] [Full Text] [Related]
6. Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC).
Elias AD; Skarin AT; Leong T; Mentzer S; Strauss G; Lynch T; Shulman L; Jacobs C; Abner A; Baldini EH; Frei E; Sugarbaker DJ
Lung Cancer; 1997 May; 17(1):147-61. PubMed ID: 9194034
[TBL] [Abstract] [Full Text] [Related]